Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Update

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 300 shares, a decline of 25.0% from the July 15th total of 400 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 1,100 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Mannatech in a research note on Wednesday. They set a “buy” rating on the stock.

Read Our Latest Stock Report on Mannatech

Mannatech Price Performance

MTEX stock traded down $0.14 during trading on Wednesday, reaching $7.06. 13,341 shares of the company were exchanged, compared to its average volume of 1,527. The company has a market cap of $13.31 million, a P/E ratio of -7.93 and a beta of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $14.45. The stock’s 50 day moving average price is $7.26 and its 200 day moving average price is $8.01. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.56 and a current ratio of 1.08.

Mannatech (NASDAQ:MTEXGet Free Report) last released its quarterly earnings data on Tuesday, May 14th. The company reported $0.63 EPS for the quarter. The firm had revenue of $29.39 million for the quarter. Mannatech had a negative net margin of 1.31% and a negative return on equity of 15.37%.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Further Reading

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.